HealthStar names Muratore to succeed Levy
HealthStar has named Bob Muratore as Levy's successor, giving him the new title group president of agency services. Muratore also serves as executive vice president of corporate planning at HealthStar.
Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."
But demand for Enbrel and Aranesp slipped.
The candidate would be the first to put oxycodone and morphine in one capsule.